Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Lasmiditan for the Treatment of Migraines With or Without Aura in Adults (OPEN ACCESS)
2
x
$
0.00
VOL 1 No. 1 Full Issue - May 1999
1
x
$
20.00
VOL 2 No. 1 Full Issue - January 2000
1
x
$
20.00
New Developments in the Neurobiological Basis of Anxiety Disorders
1
x
$
30.00
Gregory M. Asnis, MD: IFN-Induced Depression: A Role for NSAIDs
1
x
$
30.00
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
1
x
$
30.00
Gwenn S. Smith, PhD: Applications of Neuroreceptor Imaging to Psychiatry Research
1
x
$
30.00
Gender-Specific Differences in Depression and Treatment Response
1
x
$
30.00
Graeme F. Mason, PhD: Magnetic Resonance Spectroscopy for Studies of Neurotransmission in Vivo
1
x
$
30.00
Patient Response Trajectories in Major Depressive Disorder
1
x
$
30.00
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
1
x
$
30.00
Assessment of Anxiety in Clinical Trials with Depressed Patients
1
x
$
30.00
View Cart
Checkout
Home
livermetabolism-neurotransmitter-uptake-inhibitors-o-desmethylvenlafaxine-pharmacokinetics
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Desvenlafaxine and Venlafaxine Exert Minimal In Vitro Inhibition of Human Cytochrome P450 and P-Glycoprotein Activities
$
30.00
Add to cart
Details
Page load link
Go to Top
